This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J.Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice. Value in Health 11: 4-12, No. 1, Jan-Feb 2008
Rights and permissions
About this article
Cite this article
Pemetrexed/cisplatin worth it in malignant pleural mesothelioma. Pharmacoecon. Outcomes News 548, 5 (2008). https://doi.org/10.2165/00151234-200805480-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805480-00012